CompanyGraph
Boston Scientific Corporation
BSX · NYSE Arca · United States
bostonscientific.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $65.44B, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 3.06: safe zone
- Interpretations8 currently firing — 8
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
65.44BUSDvs all stocks (USD)
Trailing P/E
18.42xRevenue (TTM)
20.61BUSDvs all stocks (USD)
Profit Margin
17.29%Beta
0.5770xvs all stocks
52-Week Change
-57.57%vs all stocks
Market Capitalization
65.44BUSDvs all stocks (USD)
Enterprise Value
75.26BUSDvs all stocks (USD)
Trailing P/E
18.42xForward P/E
11.88xPEG Ratio
0.1926xPrice to Sales (TTM)
3.17xPrice to Book (MRQ)
2.53xEnterprise to Revenue
3.65xEnterprise to EBITDA
13.68xGross Margin
69.44%Profit Margin
17.29%Operating Margin
20.60%Return on Assets (TTM)
6.08%Return on Equity (TTM)
14.66%Revenue (TTM)
20.61BUSDvs all stocks (USD)
Revenue per Share (TTM)
13.91USDUpdated Jul 18, 2026Quarterly Revenue Growth
11.60%Gross Profit (TTM)
14.21BUSDvs all stocks (USD)
EBITDA (TTM)
5.68BUSDvs all stocks (USD)
Net Income (TTM)
3.56BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
99.00%Operating Cash Flow (TTM)
4.34BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
2.81BUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
239.00MUSDFY2025 · Dec 31, 2025Revenue
20.07BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
6.22BUSDFY2025 · Dec 31, 2025Gross Profit
13.85BUSDFY2025 · Dec 31, 2025Operating Income
3.97BUSDvs all stocks (USD)
Pre-tax Income
3.38BUSDFY2025 · Dec 31, 2025Income Tax Expense
493.00MUSDFY2025 · Dec 31, 2025Net Income
2.89BUSDFY2025 · Dec 31, 2025EBIT
3.73BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
5.33BUSDFY2025 · Dec 31, 2025Research & Development
2.05BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
6.89BUSDFY2025 · Dec 31, 2025Other Operating Expenses
46.00MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
29.00MUSDFY2025 · Dec 31, 2025EPS (Basic)
1.96USDFY2025 · Dec 31, 2025EPS (Diluted)
1.94USDFY2025 · Dec 31, 2025Basic Shares Outstanding
1.48BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.48BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.89BUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
6.00MUSDFY2025 · Dec 31, 2025Operating Cash Flow
4.50BUSDFY2025 · Dec 31, 2025Free Cash Flow
3.63BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.15BUSDFY2025 · Dec 31, 2025Income Tax Paid
561.00MUSDFY2025 · Dec 31, 2025Interest Paid
319.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.89BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.37BUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-2.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
299.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
192.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-269.00MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
296.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-273.00MUSDFY2025 · Dec 31, 2025Capital Expenditures
-876.00MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-254.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
-1.59BUSDFY2025 · Dec 31, 2025Other Investing Activity
83.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.39BUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.56BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-2.05BUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-1.79BUSDFY2025 · Dec 31, 2025Other Financing Charges
-55.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.34BUSDFY2025 · Dec 31, 2025Shares Outstanding
1.49BSharesUpdated Jul 18, 2026Float Shares
1.48BSharesUpdated Jul 18, 2026Shares Short
27.94MSharesUpdated Jul 18, 2026Short Ratio
1.27daysvs all stocks
Short % of Shares Outstanding
1.88%vs all stocks
% Held by Insiders
0.23%vs all stocks
% Held by Institutions
94.04%vs all stocks
Total Cash (MRQ)
1.45BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9780USDUpdated Jul 18, 2026Total Debt (MRQ)
11.03BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.4225xCurrent Ratio (MRQ)
1.90xBook Value per Share (MRQ)
17.40USDUpdated Jul 18, 2026Total Assets
43.67BUSDvs all stocks (USD)
Total Current Assets
8.79BUSDFY2025 · Dec 31, 2025Total Liabilities
19.20BUSDFY2025 · Dec 31, 2025Total Non-current Assets
34.88BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
13.76BUSDFY2025 · Dec 31, 2025Total Current Liabilities
5.44BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.97BUSDFY2025 · Dec 31, 2025Accounts Receivable
2.93BUSDFY2025 · Dec 31, 2025Inventory
2.94BUSDFY2025 · Dec 31, 2025Accounts Payable
1.14BUSDFY2025 · Dec 31, 2025Short-term Debt
299.00MUSDFY2025 · Dec 31, 2025Deferred Revenue
313.00MUSDFY2025 · Dec 31, 2025Other Current Liabilities
482.00MUSDFY2025 · Dec 31, 2025Long-term Debt
11.14BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
2.40BUSDFY2025 · Dec 31, 2025Common Stock (Book)
17.00MUSDFY2025 · Dec 31, 2025Retained Earnings
5.57BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
24.47BUSDvs all stocks (USD)
Treasury Stock
2.25BUSDFY2025 · Dec 31, 202552-Week Low
42.20USDUpdated Jul 18, 202652-Week High
109.50USDUpdated Jul 18, 202652-Week Change
-57.57%vs all stocks
Beta
0.5770xvs all stocks
50-Day MA
48.57USDUpdated Jul 18, 2026200-Day MA
75.75USDUpdated Jul 18, 2026Avg 10-Day Volume
15.02MSharesUpdated Jul 18, 2026Avg 30-Day Volume
19.58MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
2.39USDUpdated Jul 18, 2026Other Income / Expense
-267.00MUSDFY2025 · Dec 31, 20258 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
Reads
Cash-Backed Growth Configuration
Revenue has grown steadily, and the cash arriving matches reported profit.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
Drawdown With OCF Coverage And Growth Consistency
Well below its peak, with cash covering profit and growth that has been steady.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.06: safe zoneNotable
Altman Z-Score: 3.06
High earnings qualityNotable
Earnings Quality Score: 1.43
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $65.44B, higher than 95% of all stocks globallySignificant
Market cap (USD): 65,444,217,045Global P95: 25,614,208,870.135
Revenue is $20.61B, higher than 95% of all stocks globallySignificant
Revenue (USD): 20,614,000,640Global P95: 14,667,937,174.886
Levered free cash flow is $2.81B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 2,807,124,992Global P95: 1,123,592,359.78
Companies that share the same coordination system — how they create, deliver, or capture value.
argenx SE
Tier 1ProductionApproval-Gated PipelineRule
Beigene Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Merck KGaA
Tier 1ProductionApproval-Gated PipelineRuleFlow
Regeneron Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Bayer AG
Tier 1ProductionApproval-Gated PipelineRuleFlow
UCB SA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Siemens Healthineers AG
Tier 1ProductionApproval-Gated PipelineRuleFlow
Samsung Biologics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Edwards Lifesciences Corporation
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Fortune Electric Co., Ltd.
5 interpretationsRevenue Growing With Receivables GrowingDrawdown With FCF And Cash BackingMulti-Year Revenue, Profit, And Income GrowthClose Below 40W SMA With ProfitabilityMulti-Year FCF With Growth And Margin
Vakko Tekstil ve Hazir Giyim Sanayi Isletmeleri A.S.
5 interpretationsCash-Backed Growth ConfigurationDrawdown With FCF And Cash BackingClose Below 40W SMA With ProfitabilityDrawdown With OCF Coverage And Growth ConsistencyMulti-Year FCF With Growth And Margin
DoubleVerify Holdings Inc.
5 interpretationsCash-Backed Growth ConfigurationDrawdown With FCF And Cash BackingMulti-Year Revenue, Profit, And Income GrowthDrawdown With OCF Coverage And Growth ConsistencyMulti-Year FCF With Growth And Margin